Depei Liu

Title: Depei Liu: Innovator in Homologous Recombination Techniques

Introduction

Depei Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of genetic engineering, particularly in the area of homologous recombination. His innovative work has implications for various applications in biotechnology and medicine.

Latest Patents

Depei Liu holds a patent titled "Host cells deficient for mismatch repair and their use in methods for inducing homologous recombination using single-stranded nucleic acids." This patent describes methods for inducing homologous recombination in a host cell that contains a target nucleic acid. The technique utilizes a single-stranded nucleic acid molecule that has a sufficient number of nucleotides homologous to the target nucleic acid, enabling effective homologous recombination. The host cell is characterized by a de-repressible promoter operably linked to a nucleic acid encoding a single-stranded binding protein and is deficient in mismatch repair. This innovative approach opens new avenues for genetic manipulation and therapeutic applications.

Career Highlights

Depei Liu is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding and application of genetic engineering techniques. Liu's research has garnered attention for its potential to enhance the efficiency of gene editing processes.

Collaborations

Depei Liu has collaborated with notable colleagues, including Donald L Court and Xin-tian Li. These partnerships have contributed to the development of innovative methodologies in the field of genetic research.

Conclusion

Depei Liu's contributions to the field of homologous recombination represent a significant advancement in genetic engineering. His patented methods and collaborative efforts continue to influence the landscape of biotechnology and medicine.